Coldstream Capital Management Inc 2seventy Bio, Inc. Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Coldstream Capital Management Inc holds 172 shares of TSVT stock, worth $860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
172Holding current value
$860% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TSVT
# of Institutions
145Shares Held
44.8MCall Options Held
109KPut Options Held
2.9K-
Kynam Capital Management, LP Princeton, NJ5.95MShares$29.8 Million1.11% of portfolio
-
Goldman Sachs Group Inc New York, NY4.68MShares$23.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$18.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.92MShares$14.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$14.1 Million0.0% of portfolio
About 2seventy bio, Inc.
- Ticker TSVT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,873,600
- Market Cap $189M
- Description
- 2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...